Duorui Pharmaceutical: At present, sodium acetate Ringer injection has not been included in the scope of collection in the national procurement that has been carried out

Duorui Pharmaceutical (301075) said on the interactive platform that as of now, five batches of centralized procurement of drugs organized by the state have been carried out, and from the perspective of the bidding drugs, it is mainly aimed at varieties with large clinical consumption, which have been included in the national medical insurance directory and have a number of pharmaceutical companies pass the consistency evaluation. Since sodium acetate Ringer injection has not yet entered the national medical insurance directory, and does not belong to the variety with large clinical consumption at the national level, the product has not been included in the scope of collection in the national volume procurement that has been carried out.